Cargando…
Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug Design
Rationally designing drugs that last longer in the face of biological evolution is a critical objective of drug discovery. However, this goal is thwarted by the diversity and stochasticity of evolutionary trajectories that drive uncertainty in the clinic. Although biophysical models can qualitativel...
Autores principales: | Leighow, Scott M., Liu, Chuan, Inam, Haider, Zhao, Boyang, Pritchard, Justin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000225/ https://www.ncbi.nlm.nih.gov/pubmed/32209458 http://dx.doi.org/10.1016/j.celrep.2020.02.108 |
Ejemplares similares
-
The risks of perpetuating an evolutionary arms race in drug discovery
por: Leighow, Scott M, et al.
Publicado: (2019) -
A pan-CRISPR analysis of mammalian cell specificity identifies ultra-compact sgRNA subsets for genome-scale experiments
por: Zhao, Boyang, et al.
Publicado: (2022) -
Rational drug design
por: Truhlar, Donald, et al.
Publicado: (1999) -
Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing
por: Liu, Chuan, et al.
Publicado: (2023) -
Multi-Step Usage of in Vivo Models During Rational Drug Design and Discovery
por: Williams, Charles H., et al.
Publicado: (2011)